Magyar Dermatológiai Társulat Magyar Dermatológiai Társulat 82. Nagygyűlése / VIII. Dermatopharma kiállítás - Dermatológiai Továbbképző Tanfolyam
Rendezvény kezdete: 2009.12.10.Rendezvény vége: 2009.12.12. Tudományos információ: Dr. Szegedi Andrea, egyetemi docens Munkahely neve: DEOEC Egészségtudományi Centrum Bõr- és Nemikórtani Klinika Címe: 4012 Debrecen Nagyerdei krt. 98. Tel: 06-52/ 255-602 Fax: 52/ 255-736 E-mail: aszegedi@dote.hu Szervező: Bagdi Károly Munkahely neve: Convention Budapest Kft. Címe: 1461 Budapest, Pf: 11. Tel: 06-1-2990184, -85, -86 Fax: 06-1-2990187 E-mail: kbagdi@convention.hu Helyszín: 1021 Budapest, Hárshegyi u. 5-7., Európa Kongresszusi Központ A rendezvény Web oldala: http://www.convention.hu A kongresszusi értesítő, a regisztrációs lap és a költségátvállaló nyilatkozat elérhető a kapcsolódó dokumentumokban.
Fontos határidők:
értesítés és abstract felhívás postázása: 2009. április 30. tudományos összefoglalók visszaküldése: 2009. szeptember 5. értesítés az elõadások elfogadásáról: 2009. szeptember 20. díjmentes regisztráció a Társaság tagjainak: 2009. október 10. végleges program postázása: 2009. november 10. a Magyar Dermatológiai Társulat 81. Nagygyûlése: 2009. december 10-12.
Kapcsolódó dokumentumok (4)
Magyar Osteológiai és Osteoarthrológiai Társaság Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease
Rendezvény kezdete: 2005.07.06.Rendezvény vége: 2005.07.07. Helyszín: Oxford A rendezvény Web oldala: http://www.paget.org.uk Deadline for abstracts: 11 February 2005
For full details and abstract submission form please see the Symposium website.
Speakers to include:
Roland Baron (New Haven, USA): Approaches to anabolic agents for bone
Roger Bouillon (Leuven, Belgium): Advances in Vitamin D pharmacology
Henry Bryant (Indianapolis, USA): SERMs Where next?
Hal Ebetino (Cincinnati, USA): The applications of phosphonate chemistry to bone pharmacology
Lorie Fitzpatrick (Thousand Oaks, USA): Therapeutic strategies based on blockade of the RANKL/RANK/OPG system
Ross Garrett (San Antonio, USA): Approaches to anabolic drugs via statins and the proteasome pathways
Anthony Hollander (Bristol, UK): Engineering new tissues for bone and joint disease
Stephen Krane (Boston USA): Current and future therapies in arthritis and connective tissue disease
Donald McDonnell (Durham, USA): Estrogen receptor pharmacology
Gregory Mundy (San Antonio, USA): Pharmacological approaches to interfering with tumour cell interactions in bone
Ed Nemeth (Toronto, Canada): The calcium sensing receptor as a drug target
Jack Martin (Melbourne, Australia): Cellular coupling revisited. Communication between osteoblasts and osteoclasts
Jude Onyia (Indianapolis, USA): Molecular mechanisms of PTH action
Larry Raisz (Farmington, USA): Prostaglandins and bone in 2005
René Rizzoli (Geneva, Switzerland): Entering the era of the dual action bone agent
Michael Rogers (Aberdeen, UK): Molecular insights into bisphosphonate actions
Tim Spector (London, UK): Update on osteoarthritis: pathogenesis and treatment
Magyar Osteológiai és Osteoarthrológiai Társaság Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease
Rendezvény kezdete: 2005.07.06.Rendezvény vége: 2005.07.07. Helyszín: Oxford A rendezvény Web oldala: http://www.paget.org.uk Deadline for abstracts: 11 February 2005
For full details and abstract submission form please see the Symposium website.
Speakers to include:
Roland Baron (New Haven, USA): Approaches to anabolic agents for bone
Roger Bouillon (Leuven, Belgium): Advances in Vitamin D pharmacology
Henry Bryant (Indianapolis, USA): SERMs Where next?
Hal Ebetino (Cincinnati, USA): The applications of phosphonate chemistry to bone pharmacology
Lorie Fitzpatrick (Thousand Oaks, USA): Therapeutic strategies based on blockade of the RANKL/RANK/OPG system
Ross Garrett (San Antonio, USA): Approaches to anabolic drugs via statins and the proteasome pathways
Anthony Hollander (Bristol, UK): Engineering new tissues for bone and joint disease
Stephen Krane (Boston USA): Current and future therapies in arthritis and connective tissue disease
Donald McDonnell (Durham, USA): Estrogen receptor pharmacology
Gregory Mundy (San Antonio, USA): Pharmacological approaches to interfering with tumour cell interactions in bone
Ed Nemeth (Toronto, Canada): The calcium sensing receptor as a drug target
Jack Martin (Melbourne, Australia): Cellular coupling revisited. Communication between osteoblasts and osteoclasts
Jude Onyia (Indianapolis, USA): Molecular mechanisms of PTH action
Larry Raisz (Farmington, USA): Prostaglandins and bone in 2005
René Rizzoli (Geneva, Switzerland): Entering the era of the dual action bone agent
Michael Rogers (Aberdeen, UK): Molecular insights into bisphosphonate actions
Tim Spector (London, UK): Update on osteoarthritis: pathogenesis and treatment
Magyar Osteológiai és Osteoarthrológiai Társaság Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease
Rendezvény kezdete: 2005.07.06.Rendezvény vége: 2005.07.07. Helyszín: Oxford A rendezvény Web oldala: http://www.paget.org.uk Deadline for abstracts: 11 February 2005
For full details and abstract submission form please see the Symposium website.
Speakers to include:
Roland Baron (New Haven, USA): Approaches to anabolic agents for bone
Roger Bouillon (Leuven, Belgium): Advances in Vitamin D pharmacology
Henry Bryant (Indianapolis, USA): SERMs Where next?
Hal Ebetino (Cincinnati, USA): The applications of phosphonate chemistry to bone pharmacology
Lorie Fitzpatrick (Thousand Oaks, USA): Therapeutic strategies based on blockade of the RANKL/RANK/OPG system
Ross Garrett (San Antonio, USA): Approaches to anabolic drugs via statins and the proteasome pathways
Anthony Hollander (Bristol, UK): Engineering new tissues for bone and joint disease
Stephen Krane (Boston USA): Current and future therapies in arthritis and connective tissue disease
Donald McDonnell (Durham, USA): Estrogen receptor pharmacology
Gregory Mundy (San Antonio, USA): Pharmacological approaches to interfering with tumour cell interactions in bone
Ed Nemeth (Toronto, Canada): The calcium sensing receptor as a drug target
Jack Martin (Melbourne, Australia): Cellular coupling revisited. Communication between osteoblasts and osteoclasts
Jude Onyia (Indianapolis, USA): Molecular mechanisms of PTH action
Larry Raisz (Farmington, USA): Prostaglandins and bone in 2005
René Rizzoli (Geneva, Switzerland): Entering the era of the dual action bone agent
Michael Rogers (Aberdeen, UK): Molecular insights into bisphosphonate actions
Tim Spector (London, UK): Update on osteoarthritis: pathogenesis and treatment
Magyar Osteológiai és Osteoarthrológiai Társaság Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease
Rendezvény kezdete: 2005.07.06.Rendezvény vége: 2005.07.07. Helyszín: Oxford A rendezvény Web oldala: http://www.paget.org.uk Deadline for abstracts: 11 February 2005
For full details and abstract submission form please see the Symposium website.
Speakers to include:
Roland Baron (New Haven, USA): Approaches to anabolic agents for bone
Roger Bouillon (Leuven, Belgium): Advances in Vitamin D pharmacology
Henry Bryant (Indianapolis, USA): SERMs Where next?
Hal Ebetino (Cincinnati, USA): The applications of phosphonate chemistry to bone pharmacology
Lorie Fitzpatrick (Thousand Oaks, USA): Therapeutic strategies based on blockade of the RANKL/RANK/OPG system
Ross Garrett (San Antonio, USA): Approaches to anabolic drugs via statins and the proteasome pathways
Anthony Hollander (Bristol, UK): Engineering new tissues for bone and joint disease
Stephen Krane (Boston USA): Current and future therapies in arthritis and connective tissue disease
Donald McDonnell (Durham, USA): Estrogen receptor pharmacology
Gregory Mundy (San Antonio, USA): Pharmacological approaches to interfering with tumour cell interactions in bone
Ed Nemeth (Toronto, Canada): The calcium sensing receptor as a drug target
Jack Martin (Melbourne, Australia): Cellular coupling revisited. Communication between osteoblasts and osteoclasts
Jude Onyia (Indianapolis, USA): Molecular mechanisms of PTH action
Larry Raisz (Farmington, USA): Prostaglandins and bone in 2005
René Rizzoli (Geneva, Switzerland): Entering the era of the dual action bone agent
Michael Rogers (Aberdeen, UK): Molecular insights into bisphosphonate actions
Tim Spector (London, UK): Update on osteoarthritis: pathogenesis and treatment
Magyar Osteológiai és Osteoarthrológiai Társaság Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease
Rendezvény kezdete: 2005.07.06.Rendezvény vége: 2005.07.07. Helyszín: Oxford A rendezvény Web oldala: http://www.paget.org.uk Deadline for abstracts: 11 February 2005
For full details and abstract submission form please see the Symposium website.
Speakers to include:
Roland Baron (New Haven, USA): Approaches to anabolic agents for bone
Roger Bouillon (Leuven, Belgium): Advances in Vitamin D pharmacology
Henry Bryant (Indianapolis, USA): SERMs Where next?
Hal Ebetino (Cincinnati, USA): The applications of phosphonate chemistry to bone pharmacology
Lorie Fitzpatrick (Thousand Oaks, USA): Therapeutic strategies based on blockade of the RANKL/RANK/OPG system
Ross Garrett (San Antonio, USA): Approaches to anabolic drugs via statins and the proteasome pathways
Anthony Hollander (Bristol, UK): Engineering new tissues for bone and joint disease
Stephen Krane (Boston USA): Current and future therapies in arthritis and connective tissue disease
Donald McDonnell (Durham, USA): Estrogen receptor pharmacology
Gregory Mundy (San Antonio, USA): Pharmacological approaches to interfering with tumour cell interactions in bone
Ed Nemeth (Toronto, Canada): The calcium sensing receptor as a drug target
Jack Martin (Melbourne, Australia): Cellular coupling revisited. Communication between osteoblasts and osteoclasts
Jude Onyia (Indianapolis, USA): Molecular mechanisms of PTH action
Larry Raisz (Farmington, USA): Prostaglandins and bone in 2005
René Rizzoli (Geneva, Switzerland): Entering the era of the dual action bone agent
Michael Rogers (Aberdeen, UK): Molecular insights into bisphosphonate actions
Tim Spector (London, UK): Update on osteoarthritis: pathogenesis and treatment